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Abstract
The use of ethylenediaminetetraacetic acid (EDTA) for 
chelation in patients with diseases of the circulatory 
system has been a controversial issue for several decades. 
However, there was a lack of studies substantiating the 
perceived benefits of patients receiving chelation 
therapy. The purpose of this study was to examine the 
effect on pain and perceived benefits related to the 
quality of life for patients receiving chelation 
infusions. The theoretical framework that guided this 
study was the Health Promotion Model developed by Nola J. 
Pender. The research questions were what are the effects 
of chelation therapy on the perceptual quality of life in 
patients receiving infusions and what are the effects of 
chelation therapy on the pain of patients receiving 
infusions? The perceptual quality of life and pain 
variables were measured using the EORTC QLQ-C3 0 and the 
Medical Outcomes Study questionnaires. The Pearson 
product-moment correlation (Pearson r) and descriptive 
statistics were used to analyze the data. Content analysis 
was utilized for open-ended questions in the survey. The
iii
sample consisted of 24 clients currently receiving 
chelation therapy. The study found four areas related to 
the quality of life significant: an increase in cognitive 
functioning and a decrease in levels of fatigue, insomnia, 
and financial difficulty. Overall, pain was perceived as 
low in the majority of clients in this study. Findings 
from this study indicated that clients did notice an 
improvement of their overall health status and experienced 
little or no pain. Recommendations for future research 
were included in this study and conduction of more studies 
utilizing different methodology so as to validate the 
efficacy of alternative health treatments.
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The purpose of this chapter will be to provide an 
establishment of the problem along with the theoretical 
framework supported by current literature. The chapter 
will also include definitions of the variables and 
assumptions that are relevant to the current researcher.
Alternative health care intervention is an emerging 
concept within the health care system. Many health care 
professionals are challenged by the controversial issues 
surrounding alternative intervention versus traditional 
medical practices. There are a multitude of alternative 
interventions that include, but are not limited to, 
acupuncture, homeopathy, herbal therapies, chiropathic, 
massage, exercise/movement, high-dose megavitamins, 
spiritual healing, lifestyle diet, relaxation, imagery, 
energy healing, folk remedies, biofeedback, hypnosis, 
psychotherapy, chelation, and art-music therapy.
Purpose of the Study
The purpose of this study was to investigate the 
effect of chelation therapy upon the perception of the 
quality of life and pain of clients receiving chelation 
infusions.
Establishment of the Problem
Alternative health care interventions is a topic of 
controversy in today's medical arena. Just as there is 
diversity of health care needs, there is a diversity of 
health care practices available to address these needs. 
Jonas (1997) does not see alternative practices as a 
replacement for conventional medicine but as an adjunct 
when conventional medicine requires supplementation and 
support. Jonas (1997) concluded that alternative therapy 
is here to stay, influenced by an increasing demand and 
search for lower health care costs.
Jonas (1997) defines alternative health care 
interventions as those practices used for the prevention 
and treatment of disease that are not normally taught in 
medical schools and not generally available inside 
hospitals. It includes practices requiring highly
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specialized and competent practitioners and many over-the- 
counter products and self-care techniques.
Alternative therapies are no longer considered a fad. 
Today, many clients seek those nontraditional treatments 
(Keegan, 1998). Keegan attributes an increase in the use 
of alternative therapies to a holistic approach and the 
wish for noninvasive techniques. Discussion of alternative 
interventions with clients will result in a more informed 
decision by clients concerning the choice of alternative 
health care interventions versus traditional medicine.
Health care providers are divided on the significance 
of the trend of increased visits to alternative 
practitioners. The use of alternative interventions is 
increasing as consumers become more knowledgeable 
regarding alternative medicine. A recent survey of 1,035 
respondents showed that 40% used some type of alternative 
therapy in the past year (Astin, 1998). The increase in 
popularity of alternative interventions has led several 
insurance companies to cover certain alternative 
treatments. The significance to nursing is the need to be 
informed about new and upcoming medical treatments.
Studies validating the benefits to clients receiving 
chelation therapy will help primary care providers
consider alternative health care interventions as viable 
options to the treatment of chronic and degenerative 
diseases that affect perceptual quality of life and 
perception of pain.
In 1997, a national study surveyed 1,500 American 
adults. Forty-two percent of the population related use of 
various forms of alternative health care. The increased 
usage of alternative health care has been attributed to 
successful public relations and an increase in education 
concerning alternative care. The majority of the 
population identified with excellent health and 
satisfaction with the provider of alternative health care 
(National Council Against Health Fraud, 1998).
Jonas (1997) supports education in regard to the type 
of alternative health care practices available. The client 
should be guided by the family health care provider. 
Guidance makes it necessary for the health care provider 
to be aware of the side effects and interactions with 
standard health care practices. Jonas (1997) concluded 
that alternative therapy is here to stay.
Arteriosclerosis is one of the most debilitating 
diseases of the world today and the leading cause of 
disability and death (Walker, 1990). More than 10 million
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people in the United States suffer from cardiovascular 
disease (CVD), and more than 2 million have a myocardial 
infarction (MI) or coronary artery bypass surgery each 
year (Schaer, Stein, & McBride, 1998) . When blood vessels 
become blocked by plaque, bloodflow to vital organs is 
reduced. This blockage can cause symptoms such as chest 
pain, leg pain with walking, shortness of breath, painful 
or discolored feet, and transient loss of memory or 
vision. These symptoms may contribute to lifestyle 
limitations as well as experiences of pain with daily 
activities of living, thus affecting the perception of the 
quality of life and/or the perception of pain.
Narrowing and occlusion of vessels may occur not only 
in large vessels but also in small vessels. Vascular 
disease leads to reduced blood flow to many vital organs 
and tissues. This reduction in blood flow can result in 
the development of stroke, renal disease, mental status 
changes, and other physical changes. These complications 
can have a direct affect or effect on the quality of life 
by restriction of activities and pain. Peripheral vascular 
disease can lead to intermittent claudication which can 
cause pain with walking, exercise, or at rest. These 
conditions can produce a decrease in the perceptual
quality of life and health. "Persons who have chronic 
health conditions or disabilities are especially 
vulnerable to pain, depression, anxiety, sleeplessness, 
and lack of vitality" (U. S. Department of Health and 
Human Services, 1998).
Chelation therapy is an alternative intervention that 
has been used with clients diagnosed with problems of the 
circulatory system, such as arteriosclerosis of peripheral 
vessels, coronary heart disease, and other vascular 
diseases. Because of the triumph over infectious diseases 
and diseases of childhood, many people have begun to 
survive into old age, which has brought on a rapid rise 
and dominance of cardiovascular disease as the 
overwhelming cause of illness and death in the United 
States adult population and in other industrial nations 
(Mallory & Bahinski, 1999). This disease threatens to 
place an extraordinary burden on worldwide health care 
resources and practices of medicine by the year 2000. 
Cardiovascular disease is also seen as a cause of 
morbidity and the leading cause of death in virtually all 
countries of the world. Alternative health care 
interventions may have an effect on the perceptual quality
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of life or the perception of pain in clients receiving 
chelation intervention.
These degenerative diseases have been treated by 
traditional medical surgical treatments and medical 
treatment. In the past, traditional medicine did not 
recognize any benefits of alternative interventions in the 
treatment of vascular disease or its affect on an 
individual's perception of quality of life and pain 
(McDonagh, 1987) . However, current literature recognizes 
that there are some benefits to clients who utilize 
alternative treatments.
The American Heart Association has estimated the cost 
of cardiovascular disorders in 1998 at $259 billion. 
Surgical treatment of vascular disease is very costly. 
Today, the average bypass surgery costs over $35,000 per 
procedure (Edelson, 1995). The cost of diagnostic tests is 
not included in this cost. Chelation therapy costs 
approximately $90 to $100 per treatment. The average 
client receives 3 0 to 4 0 treatments over the course of 
approximately 3 years, resulting in a total cost of 
approximately $3,000 over a period of 3 to 4 years. This 
presents a savings of approximately $32,000. The cost 
comparison of surgery versus chelation therapy supports a
alternative interventions with clients with chronic 
diseases who may benefit from these interventions.
Also, government and private insurances continuously 
search for ways to reduce the cost of health care practice 
and to efficiently utilize health care dollars. This study 
will support the examination of alternative health 
interventions as a reduction in cost for managing chronic 
diseases. As there continues to be an increase in the use 
of alternative health care interventions, there will 
develop a need for more medical insurance companies to 
consider coverage of payments for alternative health care 
interventions. This coverage will lead to more research 
involving the benefits of alternative health practices and 
interventions.
Theoretical Framework
The Health Care Promotion Model (Marriner-Tomey & 
Alligood, 1998) will provide the theoretical framework for 
this study. Pender identifies cognitive-perceptual factors 
that are modified by situational, personal, and 
interpersonal characteristics to result in the 
participation in health-promoting behaviors. Pender 
identifies the following seven primary motivational
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mechanisms for the actions related to health promotion :
(a) importance of health, (b) perceived control of health, 
(c) perceived self-efficacy, (d) definition of health, (e) 
perceived health status, (e) perceived benefits of 
behaviors, and (f) perceived barriers to health-promoting 
behaviors (Marriner-Tomey & Alligood, 1998).
Using Pender's model, clients receiving chelation 
therapy as an alternative intervention value their health 
status which influences their decision to select 
alternatives in health care. Being in a well state is a 
top priority for these clients, and they perceive 
themselves as being in control of their wellness state. 
This perception is manifested by the decision to engage in 
an alternative intervention that gives more control to 
achieve their health status goal. The individual's self- 
efficacy and perceived health status are based primarily 
on the subjective measurements of the client's decision to 
engage in an alternative intervention. The perceived 
health benefits investigated in this study were determined 
by the subjective expressions of these clients based on 
the correlation between chelation infusions and their 
perceptual benefits from selecting and engaging in this 
alternative to mainstream medicine.
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For the purpose of this study, the individual was the 
client who received chelation therapy. The individual is 
the center of the model. The individual's choice and 
selection of chelation therapy are influenced by several 
of the primary motivational mechanisms identified in the 
Health Promotion Model. This model places responsibility 
on the individual to take an active role in the selection 
of health-promoting behaviors. The individual's definition 
and perception of health have more importance than any 
other factors that influence health.
The practitioner uses Pender's theory to promote the 
individual's health. The attainment of personal health is 
essential for health care providers and consumers. This 
theory is a primary tool in nursing research.
Statement of the Problem
Alternative methods of providing medical treatment 
for a variety of health care problems is becoming more 
popular. Traditional medicine and insurance companies 
continue to not recognize the benefits of alternative 
methods of health care ; therefore, more research is 
needed. The use of repeated chelation infusions has been 
promoted for the treatment of a wide range of disorders.
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These disorders include arteriosclerosis, intermittent 
claudication, cerebrovascular disease, and other diseases 
of the circulatory system. There have been reports of 
clinical benefits of clients who have received infusions. 
However, there is a lack of research substantiating the 
effects and benefits of chelation therapy. Thus, the 
problem investigated in this study was the effects of 
chelation therapy upon the perceptual quality of life and 
the perception of pain in clients receiving chelation 
infusions. The purpose of this study was to determine the 
effect upon the perception of the quality of life and the 
perception of pain in clients receiving chelation 
infusions.
Research Qimatinna
1. What is the effect of chelation therapy upon
perceptual quality of life in clients receiving infusions?
2. What is the effect of chelation therapy upon the
pain perception of clients receiving infusions?
Definition of Terms
For the purpose of this study, the following terms 
were defined:
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Chelation therapy: Theoretical :
. . . the incorporation of a metal into a
heterocyclic ring structure of the chelating 
agent, the result is a closed ring; when the 
metal joins the molecular structure of the 
chelating agent, the result is a closed ring.
The metal is now a part of the new structure and 
is captive of the chelating agent (McDonagh,
1987, p. 83)
Operational : the administration of
ethylenediaminetetraacetic acid (EDTA) through an
intravenous access which rids the body of toxic heavy
metals.
Perception of pain: Theoretical : ". . . a n  unpleasant
sensory and emotional experience that is normally 
associated with injury to body tissues" (Grolier 
Electronic Encyclopedia, 1993, p. 254) . Operational i. an 
unpleasant sensory and emotional experience as a result of 
occlusive arterial disease determined by subjective report 
from clients receiving chelation therapy as 
operationalized by the Medical Outcomes Study (MOS).
Effect : Theoretical : ". . . the result of something
that has been done or has happened" (Webster's Dictionary, 
1994, p. 56) . Operational : the result of chelation therapy 
on perception of quality of life and perception of pain as
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determined by subjective measurements of clients receiving 
chelation therapy.
Client : Theoretical : ". . . a n  individual awaiting or
under medical treatment" (Webster's Dictionary, 1994, p. 
118) . Operational : an individual undergoing chelation 
therapy as a form of alternative treatment.
Perceptual quality of life : Theoretical : the 
enjoyment of life that an individual experiences based on 
activities of daily living and the overall perception of 
health and the rise from deterioration (Grolier 
Encyclop e d i a 1993). Operational : an individual's 
perception of the effect of chelation therapy upon their 
health status and their overall satisfaction and enjoyment 
of life as measured by the score on the European 
Organization for Treatment and Research of Cancer Quality 
of Life Questionnaire (EORTC QLQ-C3 0).
Assumptions
For the purposes of this study, the following 
assumptions were made :
1. Clients used chelation therapy by infusion as an 
alternative treatment to traditional medicine.
15
2. Individuals with chronic disease perceived an 
optimal level of functioning as a realistically obtainable 
state or goal.
3. Individuals were motivated to engage in health 
promotion behaviors, perceived benefits, and treatments.
4. Subjective benefits related to pain and quality of 
life were measured with clients receiving chelation 
therapy.
Chapter II 
Review of the Literature
The benefits of chelation infusions have been a 
controversial issue for several decades. There have been 
several studies that have investigated objective and 
subjective benefits of chelation infusions. This chapter 
will provide a critical evaluation of the review of 
literature and the variables under investigation.
Van Rij, Solomon, Packer, and Hopkins (1994) 
investigated the benefits of chelation therapy in patients 
with intermittent claudication. In their review of the 
literature. Van Rij et al. (1994) cited that much of the 
literature lacked the supportive evidence of experiments 
and appropriately designed clinical trials. The authors 
also cited many claims for the benefits of chelation 
therapy that were based on uncontrolled studies.
Van Rij et al. (1994) conducted a single-center, 
double-blind, randomized controlled trial in a group of 
patients to identify significant benefits of chelation 
therapy among patients with intermittent claudication.
16
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These benefits were measured by obtaining subjective and 
objective data including (a) segmental pressure and pulse 
volume plethsymography and femoral and posterior tibial 
artery pulsatility indices, (b) exercise on treadmill, (c) 
level of cardiac function efficiency, and (d) behavior and 
attitudes related to lifestyles.
A sample of patients was recruited from the Dunedin 
Hospital Peripheral Vascular Disease Clinic. Criteria for 
inclusion were patients with atherosclerotic disease 
confirmed by arteriography, over the age of 45 years, and 
with no debilitating disease, diabetes, or significant 
renal disease. The final sample consisted of 32 patients 
who met the criteria, agreed to participate, and completed 
the treatment. Sample size required was calculated from an 
algorithm that combined retest reliability of outcome 
measures. Type I error rate, and power to detect a minimum 
difference in effect size between treatment (n = 15) and 
control group (n = 17). Subjects were randomized in blocks 
of 10 with assigned infusions prepared by the hospital 
pharmacists. Each patient received 2 0 infusions, twice per 
week over 10 weeks. The infusions were indistinguishable 
by label, color, or container.
18
Van Rij et al. (1994) found significant improvement 
in the walking distance of both groups at the end of the 
infusion program. However, the measurement of subjective 
walking distances as well as post-exercise ABI were not 
significantly different during treatment or follow-up. No 
significant differences in skinfold flow, transcutaneous 
oxygen, or pulse volume recordings after treatment 
emerged. Resting ankle and brachial indices of both the 
better and worse legs showed improvement of 0.1 in two 
patients in each group (p < .05). There were no other 
changes in parameters of peripheral vascular function at 3 
months after the treatment.
Changes in lifestyle parameters at the end of the 
period showed no difference between the two groups. The 
level of usual activity and low intensity and mild to 
moderate activity exercise all improved with the chelation 
group. Van Rij et al. found no benefits on assessed level 
of fatigue, physical well-being, mood, general quality of 
life, or on the specific effect of arterial disease on 
quality of life, work, home management, and social or 
private leisure activities.
The researchers concluded that chelation therapy 
provided no immediate benefit on peripheral vascular
19
hemodynamics, functional measures of activity, lifestyle, 
quality of life, or perceptions of health related to 
peripheral vascular disease when compared with a control 
group. Van Rij et al. concluded that the significance of 
improvement established with the assessments in the late 
findings would require further study.
This study was chosen for review because of 
similarities to the current researcher's endeavors. Van 
Rij et al. helped identify key methods of controlling 
variables. Also, the study design assisted the current 
researcher in maximizing variance control within the 
researcher's current study.
In another study, Olszewer, Sabbag, and Carter (1990) 
investigated the benefits of sodium magnesium (NaMg)- 
ethylenediaminetetraacetic acid (EDTA) in peripheral 
vascular disease. In their review of the literature, 
Olszewer et al. (1990) found that there were no double- 
blind clinical trials evaluating the effects of NaMgEDTA 
in the treatment of peripheral vascular disease.
Therefore, the researchers employed a double-blind 
clinical trial with evaluation of the findings based on
(a) the walking test, (b) the master test, and (c) the 
bicycle stress test.
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A sample of 10 male patients with a mean age of 47 
years with peripheral vascular disease was enrolled in the 
study. They all had intermittent claudication and 8 of the 
10 had smoked and quit 6 months prior to the start of the 
study. The 10 patients were randomly and equally divided 
into two groups. Both groups received the nutritional 
additives to the intravenous solution. EDTA and distilled 
water were divided and supplied in unidentifiable bottles 
for infusion.
Data were obtained on 10 patients after 10 chelation 
treatments and 10 placebo infusions. At the end of the 
first 10 sessions, Olszewer et al. (1990) decided to break 
the code and continue the study on a single-blind basis. 
This decision was based on the significant improvement 
seen in one group later determined to be receiving EDTA. 
There was no control group for the next 10 sessions, and 
all subjects (N = 10) received the EDTA. Data were again 
collected at the end of the 20 sessions.
These data were analyzed with the repeated means 
method. Olszewer et al. (1990) found significant 
improvement in the three areas of clinical evaluation. At 
the end of the first 10 sessions, the walking distance 
doubled in the group receiving EDTA. After the 2 0*̂^
21
infusion, the EDTA group walked nearly three times the 
distance when compared to the distance before the 
treatment (p = .06 for the walking and p = .07 for the 
master step). There were time effects and significant 
differences between baseline treatments and 10 treatments 
(p = .025). The EDTA group doubled the distance walked 
before therapy. The researchers concluded that chelation 
had a significant impact on the walking distance, the two- 
step exercise test, and the bicycle stress test.
This study was chosen for review because of 
similarities to the current researcher's endeavors. 
Olszewer et al. (1990) helped to identify the need for 
incorporation of the variable of time into data analysis.
In another study, Guldager et al. (1992) investigated 
the effect of chelation treatment with EDTA in patients 
with severe intermittent claudication. Guldager et al. 
(1992) cited that no controlled clinical trials had been 
published on the possible effects of chelation therapy in 
patients with arteriosclerosis.
Guldager et al. (1992) conducted a randomized, 
double-blind, and placebo-controlled clinical trial in a 
group of patients. Significant benefits of chelation 
therapy among patients with intermittent claudication were
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identified. The subjects (N = 159) were patients from 
several departments of vascular surgery in Denmark. The 
sample included patients over 40 years of age who suffered 
from stable intermittent claudication for at least 12 
months. Benefits were measured by obtaining subjective and 
objective data : (a) pain free walking distance, (b)
maximal walking distance, (c) ankle/blood pressure index 
of each extremity, and (d) subjective evaluation of 
improvement.
The sample of randomized clients were assigned to 
either an experimental or a control group. Prior to 
treatment, a physical exam was performed which included 
serum and urine tests. Verbal and written instructions 
were given regarding smoking cessation, physical training, 
dietary advice, and weight loss. Experimental and control 
solutions were prepared by the pharmacy. A total of 2 0 
infusions over 5 to 9 weeks were completed in the 
outpatient department.
The effect of chelation therapy with EDTA was 
evaluated after the 2 0*̂  ̂ infusion and at 3 and 6 months. 
Changes in parameters from pre-treatment to post-treatment 
in each patient were evaluated by analysis of variance.
Sex, treatment, and smoking status were taken into
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consideration. The interaction between treatment and sex, 
treatment and smoking, and age was simplified by- 
eliminating non-significant (p > .05) model terms. 
Subjective impression of the treatment was evaluated using 
the Wilcoxon test. Guldager et al. found no significant 
changes between the two groups with regard to medications, 
weight, diet, tobacco consumption, or exercise during the 
study. No significant increases in walking distance were 
noted in the group receiving EDTA or the placebo group. 
Ankle/brachial indexes were not significantly changed in 
either group. Subjective evaluation in both groups 
revealed 50% of the patients reported their intermittent 
claudication unchanged and the other 50% reported 
improvement. Serum alkaline phosphate lab for the EDTA 
group changed significantly (p = .001). General, 
nonspecific side effects were identified but were not 
significant.
The researchers concluded that chelation therapy with 
EDTA did not demonstrate any effect in treatment of 
patients with intermittent claudication. Walking distance, 
pain-free walking distance, and ankle/brachial index 
parameters remained unchanged. Subjective evaluation 
showed no differences in the patient impression of the
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therapeutic effect. Therefore, the researchers concluded 
that EDTA does not have a potential role in the clinical 
therapy and management of peripheral vascular disease. The 
researcher identified no recommendations for future 
studies.
The chosen study was reviewed due to the similarities 
to the current researcher's endeavors. This investigation 
also helped the current researcher to identify demographic 
and social habits of potential importance to the current 
study.
In a similar study, Olszewer and Carter (1988) 
investigated the effect of EDTA chelation therapy in 
chronic degenerative disease. In their review of the 
literature, the authors found that the benefits and 
effects of the administration of EDTA were found 
coincidentally in patients who were receiving the 
chelation for other reasons and found a lack of credible 
controlled clinical trials or double-blind studies of the 
effectiveness of EDTA.
Olszewer and Carter (1988) conducted a retrospective 
study of 2,870 patients with chronic degenerative diseases 
who were treated at a private clinic to identify 
significant benefits of chelation therapy. These benefits
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were measured by obtaining objective: (a) clinical
evaluation, (b) laboratory exams, (c) EKG, and (d) stress 
tests.
The sample of patients was from a private clinic in 
Sao Paul, Brazil. The protocol used was developed with 50 
mg of EDTA per kilogram of body weight given in an IV 
infusion over a period of 3 to 3^ hours. Vitamins C, B 
complex, and magnesium were added to the solution for a 
total of 20 to 40 treatments. The treatments were given 
two to three times per week. The patients were also given 
orally combined multivitamin, mineral, and trace element 
preparations. They were encouraged to change their eating 
habits and to engage in a regular exercise program.
The patients were classified into the following 
vascular and degenerative disease categories : (a) cardiac,
(b) peripheral vascular, (c) cerebrovascular and 
degenerative CNS disease, (d) scleroderma, and e) other 
geriatric vascular diseases. Patients were evaluated 
clinically according to claudication levels at rest and 
after stress, local temperature changes, trophic changes, 
and blood pressure and pulse. The noninvasive studies 
performed were Doppler with paper register and ultrasound. 
The results were classified into five groups according to
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the following scale: (a) 4+, complete recovery; (b) 3 + ,
good recovery; (c) 2 + ,  regular recovery; (d) 1+,
unchanged; and e) 0, worse than before treatment.
The results of this study revealed a total of 76.89% 
of the patients had a marked improvement, 16.5% were rated 
as having a good improvement, 3.79% were rated as having 
moderate improvement, and 2.5% were unchanged. Only 0.1% 
of the patients became worse. The results of this 
retrospective analysis suggest that chelation therapy with 
di-sodium magnesium EDTA was useful in the therapy of 
several thousand patients with chronic degenerative, 
especially cardiovascular diseases.
This study was significant to the current research 
because of the similarities. This retrospective study 
investigated the subjective effects of chelation therapy 
upon the clients.
In another study Casdorph (1981) investigated the 
effects of chelation therapy on the ejection fraction of 
the left ventricle in patients with arteriosclerotic heart 
disease. The purpose of this study was to not only observe 
a clinical response to chelation therapy, but to record 
objective measurements of cardiac function before and at 
the end of 2 0 infusions of the drug.
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The sample size included 18 patients with documented 
arteriosclerotic disease. All patients had a complete 
physical and cardiac evaluation prior to the onset of 
therapy. Left ventricular fraction ejections were taken 
before and after the administration of chelation therapy. 
Each patient served as his or her own control by being 
studied before and at the end of the chelation infusions. 
The infusions were given once per week and were 
administered over a period of 3 hours in an office 
setting. During the chelation therapy, vitamin and mineral 
supplements were administered orally.
These data showed a statistically significant 
increase in the mean ejection fraction after the use of 
the chelation drug (p < .0005). All patients improved 
clinically and in all but two there was a complete 
subsidence of angina during the course of chelation 
therapy. Of the two patients who did not have complete 
relief of chest pain, one patient had a marked 
amelioration of cardiac symptoms and the second patient 
had a 5 0% decrease in angina and a 12% increase in 
ejection fraction.
The author concluded that the intravenous 
administration of EDTA had been shown to bring clinical as
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well as objective improvement in patients with documented 
arteriosclerotic heart disease. A statistically 
significant improvement was shown in the left ventricular 
ejection fraction in this group of patients who received 
chelation therapy.
This study is significant because of the similarities 
of investigating the effects of chelation therapy upon 
clients with arteriosclerotic changes. The current study 




The purpose of this study was to determine the effect 
upon the perceptual quality of life and perception of pain 
in clients receiving chelation infusions. This chapter 
describes the research methods used to investigate the 
variables studied. The design, population, sample, and 
setting as well as instrumentation and methods of data 
collection are described in this chapter.
Design of the Study
A descriptive design was utilized to determine the 
effects of chelation therapy upon the perceptual quality 
of life and pain perception of clients receiving chelation 
therapy. A descriptive design is utilized to observe, 
describe, and document the aspects of a situation as it 
naturally occurs with no manipulation of variables (Polit 
& Hungler, 1995). Therefore, a descriptive design was 




The dependent variables were the perception of the 
quality of life and the perception of pain in clients 
receiving chelation infusions. The independent variable 
within this study was the infusion of chelation drugs. The 
extraneous variables included the truthfulness of the 
subjects in completing the questionnaires, the subjects' 
age, race, past medical histories, and the use of other 
alternative interventions.
Research Questions
The following research questions were answered as a 
result of this study:
1. What is the effect of chelation therapy upon the
perceptual quality of life in clients receiving infusions?
2. What is the effect of chelation therapy upon the
perception of pain in clients receiving infusions?
Limitations
The following limitations were identified for this 
study :
1. The small sample size of this study made the 
results ungeneralizable.
2. The use of only one clinic in a southeastern state 
made the results ungeneralizable.
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3. The wide range of past medical histories and the 
use of various medications may have influenced or impacted 
the clients' perceptions.
Setting;, Population, and-Sample
The setting for this study was a city in northeast 
Mississippi with a population of approximately 33,000 in 
the city and 64,000 in the surrounding county. The setting 
was one private clinic utilized for chelation therapy.
The population studied were clients receiving 
chelation infusions. The sample of convenience consisted 
of 24 participants between the ages of 2 0 and 70 years who 
were currently receiving infusions and were willing to 
participate in the study.
Methods of Data -Collection
This section describes the method of data collected.
A description of instrumentation procedures and method of 
data collected are included.
Instrumentation. The Medical Outcomes Study (MGS), a 
12-item questionnaire, was used in this study (see 
Appendix A ) . The items included on the severity and 
effects of pain scales all correlated 0.5 or greater with 
their scale scores. Lateral consistency overall was 0.93;
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for the effects score it was 0.91 and the severity score 
was 0.86. Correlation of the four pain measures with 15 
criterion scores ranged from 0.43 to 0.57 (Sherbourne,
1992) . These ranges supported the accuracy and consistency 
of measurement of pain. The MOS pain effects score was 
calculated by averaging across all six items, giving a 
score from 1 to 5 for each item; this was transformed to a 
0 to 100 scale for the total score.
The European Organization for Treatment and Research 
of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) 
used in this study was a 30-item questionnaire (see 
Appendix B ) . The EORTC QLQ-C3 0 used a linear 
transformation to standardize the raw score so that the 
scores range from 0 to 100 ; a high score represents a 
higher (better) level of functioning, or a higher (worse) 
level of symptoms (EORTC QLC Scoring Manual C3 0, 1995) . 
Validity and reliability had been established by a panel 
of experts, but no statistics were found regarding 
reliability and validity. Demographic data were elicited 
through an 11-item questionnaire (see Appendix C ) . These 
included age, gender, race, routine medications, previous 
surgeries/illnesses, hospitalizations, number of 
treatments, time period that treatments were received.
33
diagnoses, social habits, and other alternative 
interventions that were used by the respondent. Also 
included was one open-ended question to assess any other 
information regarding benefits of chelation therapy or 
information that the respondent would like to share.
Procedures
Following approval by the Committee on Use of Human 
Subjects in Experimentation at Mississippi University for 
Women (see Appendix D), the proposed site was contacted by 
letter (see Appendix E) for permission to distribute 
questionnaires to obtain information on the benefits of 
chelation therapy and demographic information about 
clients receiving chelation infusions. Subjects were 
informed both verbally by the staff nurse and with written 
instructions on the process of answering the questions. A 
clipboard and writing tool were provided by the 
researcher. The staff registered nurse was trained in the 
administration of the questionnaires by the researcher.
The staff registered nurse was trained in the 
administration of the questionnaires by the researcher.
The researcher reviewed all parts of the research and the 
directions related to the questionnaires with the clinic
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staff registered nurse. The staff registered nurse working 
at the clinic administered the questionnaires which 
included a description of the purpose of the study and the 
participants' written consent (see Appendix F).
Method of Data Analysis
Data were analyzed using the Pearson product-moment 
correlation coefficient and descriptive statistics. The 
variables were measured on the ratio scale. Descriptive 
statistics were used to analyze the demographic 
characteristics of the respondents.
chapter IV 
The Findings
The purpose of this study was to determine the 
effects of chelation therapy upon the perceptual quality 
of life and perception of pain. A descriptive survey 
design was used for the study because it allowed the 
researcher to survey the effects of chelation therapy upon 
the perceptual quality of life and perception of pain.
This chapter presents a description of the sample and the 
results of data analysis related to the research 
questions. Additional findings revealed during this study 
are also presented.
Description of__the .Bangle
The sample consisted of 24 clients who received 
chelation therapy at a clinic in North Mississippi during 
a 2 -week period. The Demographic Questionnaire as utilized 
to characterize the participants. Sixteen (66.7%) of the 
sample were Caucasian, 4 (16.7%) were African American,
and 4 (16.7%) were Hispanic. Fifteen (62.5%) of the
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participants were male, and 9 (37.5%) were female. At the 
time of the study, 3 (12.5%) of the participants had 
received a total of one to five chelation treatments, 14 
(58.3%) had received 10 to 2 0 chelation treatments, and 7 
(29.2%) had received over 30 chelation treatments. A large 
number (n = 15, 62.5%) of the group were over 60 years of
age. The next largest age group consisted of individuals 
ages 51 to 60 (n = 6) which represented 25% of the sample. 
Forty-one to 50 years old (n = 2) represented 8.3% of the 
sample. A smaller number (n = 1, 4.2%) included
individuals between the ages of 31 and 40 years.
Thirteen (54.3%) of the sample received chelation 
therapy over 6 months, 5 (20.8%) received chelation
therapy from 6 to 12 months, 3 (12.5%) of the sample
received chelation therapy from 1 to 2 years, 2 (8.3%) of
the sample received treatments from 3 to 5 years, and 1 
(4.2%) received chelation treatments from 5 to 10 years.
Analysis of medications consumed routinely, previous 
surgical procedures, and hospitalizations were also 
identified. A summary of the current diagnoses, social 
habits, and the use of alternative interventions is 
presented in Table 1. A section was included for client
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comments. These additional findings will be discussed in 
Chapter V.
Table 1
Summary of Current Diagnoses, Social Habits, and Use of




Coronary artery disease 13 54 .2
Arteriosclerosis 6 25 . 0
Cerebral vascular disease 8 33 .3
Other diagnoses 5 20 . 8
Social habits
Smoker 7 29.2
Exercise 14 58 .3
Diet restrictions 6 25.0
Alcohol intake 4 8.3





®No. of participants reporting.
The Medical Outcomes Study (MOS) was utilized to 
determine the perception of pain. The domains included
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bodily pain, pain and discomfort, duration of pain, pain 
associated with activities of daily living, and average 
and worst pain in the past 4 weeks.
The European Organization for Treatment and Research 
of Cancer Quality of Life Questionnaire (EORTC QLQ-C3 0), a 
30-item questionnaire, was utilized to determine the 
effects of chelation therapy on the quality of life. 
Functional scales included physical functioning, role 
functioning, emotional functioning, cognitive functioning, 
and social functioning. Symptom scales included fatigue, 
nausea and vomiting, pain dyspnea, insomnia, appetite 
loss, constipation, diarrhea, and financial difficulties. 
Global health status was also included.
Results of Data Analysis
The purpose of this study was to determine the effect 
of chelation therapy upon the perceptual quality of life 
and the perception of pain in clients receiving infusions. 
Data were elicited utilizing a demographic questionnaire, 
the MOS, and the EORTC QLC-C3 0 in order to answer the 
following research questions :
1. What is the effect of chelation therapy on the 
perceptual quality of life in clients receiving infusions?
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2. What is the effect of chelation therapy on the 
perception of pain in clients receiving infusions?
The first research question for the study was "what 
is the effect of chelation therapy upon the perceptual 
quality of life in clients receiving infusions?" Data were 
analyzed using Pearson correlation statistics in a one­
tailed test with a p value of < .05 (critical r = 0.344) . 
With regard to quality of life, four significant items 
were identified by the EORTC QLQ-C30. These included an 
increase in cognitive functioning (p = .30), decrease in 
fatigue symptoms (p = .021), decrease in insomnia (p = 
.003), and a decrease in financial difficulty (p = .026) 
(see Table 2).
Table 2
Correlations of Chelation Treatments with EORTC QLQ-C3Q
Scales r P
SPF . 127 .277
SRF . 079 .357





SCF .388 . 030*
SSF .319 . 065
GQL . 194 . 182
SFA .418* . 021
SNV . 123 .284
SPA .050 .408
SDY . 070 .373
SSL .540* .003
SAP . 022 .459
SCO . 128 .275
SDI . 101 .319
SFI .402* . 026
Note■ N = 24. SPF = Personal functioning. SRF = Role 
functioning, SEF = Emotional functioning, SCF = Cognitive 
functioning, SSF = Social functioning, GQL = Global health 
status, SFA = Fatigue, SNV = Nausea and vomiting, SPA = 
Pain, SDY = Dyspnea, SSL = Insomnia, SAP = Appetite loss, 




The second research question for the study was "what 
is the effect of chelation therapy upon the perception of 
pain in clients receiving infusions?" Descriptive 
statistics were used to analyze these data. A large 
percentage (64.44%) rated their bodily pain on a scale of 
none to mild, while 28.9% rated their pain from moderate 
to severe. Only 6.66% rated their pain as extreme. 
Interference in activities of daily living due to pain 
indicated that 54.87% had no interference. Duration of 
pain experienced was less than 60 minutes by 87.5% of the 
clients and 12.5% experienced pain from several hours to 
more than 2 days. A "little bit" of pain was experienced 
by 29.78% and "quite a bit" to moderate pain was 
experienced by 7.69% (see Table 3).
Table 3
Ratings of Pain of Clients Receiving Chelation Therapy 
Expressed in Frequencies and Percentages
Pain %
Intensity of pain
None to mild 64 .40
Moderate to severe 28 . 90






60 minutes or less 87.50
Several hours to > 2 days 12 . 50
Interference with activities
of daily living
None 54 . 87
Little bit 29.78
Quite a bit to moderate 7.69
Extremely 7.66
Note. N = 24.
Additional. Findings
Several additional findings were identified during 
the study. Two of the clients reported that although they 
had no known disease, they were utilizing chelation 
therapy as a prevent at ive measure against disease. A large 
percentage (75%) of the research participants engaged in 
additional forms of alternative interventions including 
vitamins, herbs, magnets, and chiropractors. Although for 
the most part, chelation therapy is not covered by 
insurances, one insurance company was found to cover the 
costs of chelation therapy.
Chapter V 
The Outcomes
Alternative health care practices are a source of 
controversy among health care providers. Consumers of 
health care recently have been bombarded via the media 
about the pros and cons of a variety of alternative 
therapies. Because of the confusion among health care 
providers and the inevitable questions from consumers, it 
is essential for the health care provider to be familiar 
with new practices and interventions that may ultimately 
benefit these clients. There is very little research on 
the benefits of chelation therapy to clients receiving 
infusions. Thus, a descriptive survey design was used to 
determine the perceived quality of life and perceived pain 
control of clients receiving chelation therapy. Pender's 
nursing theory (Marriner-Tomey & Alligood, 1998) provided 
the theoretical basis for this study. The following 
research questions guided this study:
1. What is the effect of chelation therapy upon the 
perceptual quality of life of clients receiving infusions?
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2. What is the effect of chelation therapy upon the 
pain perception of clients receiving infusions?
Three instruments were used to collect data. A 
Demographic Questionnaire was used to determine the 
demographic variables of age, race, preexisting illnesses, 
current medications, number of treatments, and the use of 
other alternative interventions. The Medical Outcomes 
Study (MGS) was used to assess the perception of pain. The 
European Organization for Treatment and Research of Cancer 
Quality of Life Questionnaire (EORTC QLQ-C3 0) was used to 
determine the perceptual quality of life. This chapter 
provides a discussion of the findings and presents 
conclusions, implications for nursing, and recommendations 
for future investigations.
Summary of Findings
The sample consisted of 24 clients receiving 
chelation therapy. The largest number (n = 15, 62.5%) were 
over 60 years old. The age group of 51 to 60 included 6 
(25%) of the group. Forty-one to 50-year-old included 2 
(8.3%) of the sample. A smaller number (n = 1, 4.2%) 
included individuals between the ages of 31 and 40 years. 
Males represented 15 (62.5%) of the sample, and females
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represented 9 (37.5%) of the sample. Caucasians 
represented 16 (66.7%) of the sample, and 8 (16.7%) were
African American. Sixteen (54.3%) of the sample received 
treatments from 0 to 6 months, 5 (20.8%) received 
treatments from 6 to 12 months, 3 (12.5%) of the sample 
received treatments from 6 to 12 months, 2 (8.3%) received
treatments from 3 to 5 years, and one received treatments 
from 5 to 10 years.
Fifty-four percent (n = 13) of the sample had 
coronary artery disease. Twenty-five percent (n = 6) of 
the sample had arteriosclerosis. Thirty-three percent 
(n = 8) of the sample had cerebral vascular disease. The 
other 2 0% had diagnoses, such as hypertension, diabetes, 
and angina. Fifty-eight percent (n = 14) of the sample 
exercised regularly. Twenty-five percent (n = 6) of the 
sample were on dietary restrictions. Also, 29.2% (n = 7) 
of the sample were smokers. Other alternative 
interventions were used by 89% of the sample which 
included herbal treatments, vitamin therapy, and 
chiropractics.
The first research question for this study was to 
determine the effects of chelation therapy upon the 
perpetual quality of life. The effect of chelation therapy
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on the perceptual quality of life revealed that only 4 of 
the 15 domains were statistically significant values: (a)
cognitive functioning (p = .030), (b) decrease in fatigue
(p = .021), (c) decrease in insomnia (p = .003), and (d)
decrease in financial difficulty (p = .026).
The second research question was to determine the 
effects of chelation therapy upon the perception of pain.
A large percentage (64.44%) of clients rated their bodily 
pain on a scale of none to mild, while 2 8.9% rated their 
body pain on a scale of moderate to very severe and 6.6% 
rated their pain as severe. Duration of pain experienced 
was less than 60 minutes by 87.5% of the clients. The 
majority of clients (54.8%) stated that pain did not 
interfere with their activities of daily living.
Discussion
Statistical findings were significant in four areas 
of the perception of the quality of life in clients 
receiving chelation infusions. There was an increase in 
cognitive functioning and a decrease in fatigue, insomnia, 
and financial difficulties. The three domains may be 
interrelated because a client who experiences decreased 
insomnia, decreased fatigue, and are less tired and
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sleeping well will most likely have better cognitive 
skills. The fourth area that was statistically 
significant, decreased financial difficulty, is probably 
related to the fact that most of the clients receiving 
chelation therapy at this clinic were financially 
independent and knew that all services were on a cash 
basis with little chance for reimbursement from health 
insurance.
These findings differ from Van Rij et al. (1994) who 
found no significant changes in behaviors and attitudes 
related to lifestyles. These differences support this 
researcher's belief that more studies related to the 
efficacy of alternative health methods are needed. No 
other studies were identified in the literature related to 
quality of life for individuals receiving chelation.
In Guidager et al. (1992) the subjects experienced no 
significant change in their pain. While this study did not 
compare pre- and post-chelation pain levels, only a very 
small percentage (6.6%) reported significant pain, and 
over half of the clients said that their pain did not 
interfere with activities of daily living. One can only 
surmise that the treatment helped clients to decrease pain 
while increasing activities of daily living.
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In a separate section of the tool, clients had an 
opportunity to add any comments related to chelation 
therapy. Ten clients responded with the overwhelming 
sentiment being that their lives had significantly 
improved since beginning chelation therapy. Although this 
study provided a subjective measure of clients' 
perceptions whether the effect of chelation was real or 
placebo, the overall perceived health of the clients did 
improve.
The Health Promotion Model identifies motivational 
mechanisms for the client which include perceived benefits 
of behavior and selecting healthy lifestyle behaviors. The 
findings of this study showed that clients included the 
use of other alternative interventions and dietary changes 
which promoted healthy lifestyles. While it may be that 
these were perceived, rather than actual benefits, they 
often improved a client's overall perception of their 
health. The findings of this study support the Health 
Promotion Model's basic tenets that a client who is 
motivated by the perception of the importance of health- 
promoting behaviors, perceived control of his or her own 
health, the perception of efficacy of healthy behaviors.
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and finally the perceived benefits of the behaviors will, 
therefore, engage in activities to support these beliefs.
In this study the clients were very motivated and 
felt very strongly that these behaviors were efficacious 
as well as beneficial. The clients also perceived that 
going to the clinic on their own was a way of controlling 
their own health. Approximately 80% engaged in additional 
alternative methods as an adjunctive therapy to chelation. 
The findings of this study support the establishment of 
the problem and the theoretical framework. The Health 
Promotion Model identifies motivational mechanisms for the 
client which include perceived benefits of behavior and 
selecting healthy lifestyles. The findings of the study 
showed the use of other alternative interventions and 
dietary changes promoted healthy lifestyles for the 
clients who took part in the study.
Limitations
The researcher identified several limitations of this 
research study. The sample was small; therefore, it would 
be difficult to generalize to a larger population. The 
sample only included clients currently receiving chelation 
therapy at one clinical site; therefore, the perception of 
benefits received may have been biased. Another limitation
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was that the researcher had no way of knowing the clients' 
prior health status. Although most stated that they felt 
better, the researcher had no data to compare the client's 
health status pre- and post-study.
Conclusions
This research found that four distinct areas related 
to quality of life improved and that pain among this 
population of clients, nearly all of whom had a chronic 
illness, was negligible. This researcher inferred that 
clients' overall perception of their health had 
significantly improved since the initiation of chelation 
therapy. The clients seemed convinced that this was a 
positive health behavior, thus supporting the current 
trend of increased usage of a myriad of alternative 
therapies.
The difference between the positive results of this 
study and the few other existing studies, which found no 
improvement or changes in the clients' quality of life or 
pain, points out the need for further studies in this 
area. Alternative methods are often expensive and not 
covered by health insurance companies. Therefore, it is 
imperative to either validate their significance or 
quantify their uselessness as valid medical therapies.
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Implications .for Nursing
This study had several implications for nursing that 
were derived from the findings. Consumers and clients are 
often knowledgeable regarding alternative practices and 
other interventions. These same consumers will often seek 
out health care providers to answer questions related to 
these regimens. Education for health care providers 
regarding the use and implications of alternative 
therapies is, therefore, essential for nursing. Because 
chelation along with other alternative methods are very 
vogue now, the nurse practitioner needs to be prepared to 
answer queries related to these methods.
Currently, many alternative practices have not been 
recognized by medical planners, insurance companies, or 
health care policy makers. Recently, many of those same 
planners, companies, and policymakers have begun to take a 
second look at these methods and even suggested 
reimbursement for certain alternative therapies. Research 
that includes the study of alternative practices should be 
conducted so that these methods can be validated if they 
are useful in the treatment of disease. Nurse 
practitioners can be an integral part of investigational 
studies related to alternative practices. By expanding
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this study, a multitude of alternative methods and their 
effects on a clients health can be studied.
Recommendations for Further Study
Based upon the findings of this study, the following 
recommendations are made :
Re se archie
1. Replication of this study in another geographical 
area with a larger sample size.
2. Conduction of a similar study with a longitudinal 
research design that could follow the client over a longer 
period of time.
3. Replication of this study which allows the 
researcher to compare the client's health status prior to 
and during chelation therapy.
1. Education of health care providers with 
information related to both traditional and alternative 
health care methods.
2. Conduction of more research which incorporates the 
Health Promotion Model in examining health behaviors.
3. Encouragement by health care providers to 
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Medical Outcomes Study (MGS)
1. How much bodily pain have you generally had during the 
past 4 weeks? (Circle one)
  None




  Very severe
2. During the past 4 weeks, how often have you had pain or 
discomfort? (Circle one)
  Once or twice
  A few times
  Fairly often
  Very often
  Every day or almost every day
3. When you had pain during the past 4 weeks, how long did it 
usually last?
  A few minutes
  Several minutes to an hour
  Several h ours
  A day or two
  More than 2 days
4. During the past 4 weeks, how much did pain interfere with
the following things : (Circle one number on each line)
Not A Quite
at little a
all b i L bit Moderately Extremely
a . Your mood 1 2 3 4 5
b. Your ability to
walk or move about 1 2 3 4 5
c. Your sleep 1 2 3 4 5
d. Your normal work
(including both work
outside the home and
housework) 1 2 3 4 5
e. Your recreational
activities 1 2 3 4 5
f. Your enjoyment of
life 1 2 3 4 5
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During the past 4 weeks, how many days did pain interfere 
with the things you usually do?
(Your answer may range from 0 to 28 days)
Write in number of days :_______________
Please circle the one number that best describes your pain 





0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 15 17 18 19 20
Please circle the one number that best describes your pain










EORTC OLO-C30 (version 3)
We are interested In som e things about you and your health. Please answer all of the questions 
yourself by circling the  number that best applies to  you. There are no "right" or "wrong" answers. 
The information th a t you provide will remain strictly confidential.
Please fill in your inititals:
Your birthdate (Day, Month, Year): 
T oday 's date (Day, Month, Year):
1 - I . . . I  -L .! , U  
31 I I I I I I I
1. Do you have any trouble doing strenuous activities, 
like carrying a heavy shopping bag or a suitcase?
2. Do you have any trouble taking a long walk?
3. Do you have any trouble taking a short walk outside
of the house?
4. Do you need to  stay  in bed or a chair during the day?
5. Do you need help with eating, dressing, washing
yourself or using the  toilet?
Not at A Quite Very
All Little a Bit Much
During the past week: Not at A Quite Very
All Little a Bit Much
6. W ere you limited In doing either your work or other 
daily activities?
7. W ere you limited in pursuing your hobbies or other 
leisure tim e activities?
8. W ere you short of breath?
9. Have you had pain?
10. Did you need to  rest?
11. Have you had trouble sleeping?
12. Have you felt w eak?
13. Have you lacked appetite?
14. Have you felt nauseated?












During the past week: Not a t A Quite Very







17. Have you had diarrhea? 1 2 3 4
18. W ere you tired? 1 2 3 4
19. Did pain interfere with your daily activities? 1 2 3 4
20. Have you had difficulty in concentrating on things, 
like reading a new spaper or watching television? 1 2 3 4
21. Did you feel tense? 1 2 3 4
22. Did you worry? 1 2 3 4
23. Did you feel irritable? 1 2 3 4
24. Did you feel depressed? 1 2 3 4
25. Have you had difficulty remembering things? 1 2 3 4
26. Has your physical condition or medical treatment 
interfered with your family life? 1 2 3 4
27. Has your physical condition or medical treatment 
interfered with your social activities? 1 2 3 4
28. Has your physical condition or medical treatm ent 
caused you financial difficulties? 1 2 3 4
For the following questions please circle the number between 1 and 7 that best 
applies to you
29. How would you rate your overall health during the past week?
1 2 3 4  5 6 7
Very poor Excellent
30. How would you rate your overall quality gf Ufa during the past week?







Height : Weight : Recent weight changes;
Please check the appropriate response(s) to the following 
questions :
1. Present age (years)
  20 to 30
  31 to 40
  41 to 50
  51 to 60
_____ Over 60
2. Gender






4 . Number of treatments
  1 to 5
  10 to 20
  Over 2 0
5. Time period of treatments
  0 to 6 months
  6 to 12 months
  1 to 2 years
  3 to 5 years
5 to 10 years 
10 to 15 years 
> 15 years
6. Medications: (Please list and include supplemental
vitamins)
7 . Previous surgeries/illnesses
65
8. Hospitalizations for illnesses
__________________________  L
J -X
9. Diagnosis (check all that apply)
  Coronary artery disease
  Arteriosclerosis disease
  Cerebral vascular disease
  Other (please specify):___
10. Social habits (Check all that apply)
  Smoker
  __ Exercise regularly




11. Other alternative interventions currently being used or 
have used in the past
12. Comments :
APPENDIX D
APPROVAL OF COMMITTEE ON USE OF HUMAN 
SUBJECTS IN EXPERIMENTATION OF 




U n iv e r s it y
for^ o m e n
Office of the Vice President for Academic Affairs 
Eudora Welty Hall 
W-Box 1603 
Columbus, MS 39701 
(601) 329-7142
Admitting Men Since 1982
March 22, 1999
Ms. Francine Glenn
c/o Graduate Program in Nursing
Campus
Dear Ms. Glenn:
I am pleased to inform you that the members of the Committee 
on Human Subjects in Experimentation have approved your proposed 
research as submitted provided you add a statement to the consent 
form that participation is voluntary and election not to 
participate will in no way affect care, that the participant may 
withdraw at any time without penalty, and that any assistant 
employed shall be trained and educated in the requirements of 
confidentiality.
I wish you much success in your research.
Sincerely,




cc: Mr. Jim Davidson
Dr. Mary Pat Curtis 
Dr. Linda Sullivan






I have been fully informed of this study 
investigating the effects of chelation therapy upon the 
perceptual quality of life and perception of pain. I agree 
to allow Francine S. Glenn to collect data from consenting 
clients at my clinic. In no way will the clients' 
willingness to participate affect the services they 
receive at this facility.
I am also aware that the information gathered at this 
facility will remain confidential and will be used in a 
masters thesis by Francine S. Glenn at Mississippi 
University for Women.
Date Signature of Physician
Date Signature of Physician
APPENDIX F 





I am a registered nurse presently pursuing a Master of 
Science in Nursing degree at Mississippi University for 
Women in Columbus, Mississippi. I am conducting a study 
that will look at the benefits of chelation therapy. Your 
opinions and experiences are very important and are needed 
to provide an accurate portrayal of your perception of the 
level of satisfaction of life and pain perception since 
receiving chelation infusions. Please assist me in this 
study by completing the attached questionnaire.
Strict confidentiality will be maintained regarding access 
to information and only group scores will be recorded.
Only my research committee will have access to data 
obtained. There will be no means of identification of 
participants with questionnaires that are filled out. I 
sincerely hope that you will complete and return the 
questionnaire to the clinic staff. If at any time during 
the questionnaire process you would like to withdraw from 
the study, please inform the clinic staff and appropriate 
actions will be taken. Please sign below indicating 
permission to participate in the study.
Thank you for your cooperation and assistance in this 
study.
Sincerely,
Francine Glenn, RN, BSN
I, ____________________________________ , agree to participate
in the study investigating the subjective benefits of 
chelation therapy.
